Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Interferon Therapy in Alpha and Delta Variants of Sars-Cov-2: The Dichotomy Between Laboratory Success and Clinical Realities Publisher Pubmed



Alirezaee A1, 2 ; Mirmoghtadaei M1, 2 ; Heydarlou H1, 2 ; Akbarian A3 ; Alizadeh Z1, 2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Children's Medical Center, Pediatrics Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran

Source: Cytokine Published:2025


Abstract

The COVID-19 pandemic has caused significant morbidity and mortality worldwide. The emergence of the Alpha and Delta variants of SARS-CoV-2 has led to a renewed interest in using interferon therapy as a potential treatment option. Interferons are a group of signaling proteins produced by host cells in response to viral infections. They play a critical role in the innate immune response to viral infections by inducing an antiviral state in infected and neighboring cells. Interferon therapy has shown promise as a potential treatment option for COVID-19. In this review paper, we review the current knowledge regarding interferon therapy in the context of the Alpha and Delta variants of SARS-CoV-2 and discuss the challenges that must be overcome to translate laboratory findings into effective clinical treatments. © 2024 Elsevier Ltd
Related Docs
View other Related Docs
1. Human Genetic and Immunological Determinants of Critical Covid-19 Pneumonia, Nature (2022)
2. Immune-Based Therapeutic Approaches in Covid-19, Biomedicine and Pharmacotherapy (2022)
3. The Role of Type I Interferon in the Treatment of Covid-19, Journal of Medical Virology (2022)
4. Immune Profiling of Sars-Cov-2; What We Know and What We Don’T Know, Iranian Journal of Allergy# Asthma and Immunology (2023)
5. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)
6. Structural Evolution of Delta Lineage of Sars-Cov-2, International Journal of Biological Macromolecules (2023)
7. Recent Findings on the Coronavirus Disease 2019 (Covid-19); Immunopathogenesis and Immunotherapeutics, International Immunopharmacology (2020)
8. Immunoediting in Sars-Cov-2: Mutual Relationship Between the Virus and the Host, International Immunopharmacology (2022)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (10)
Jila Yavarian (2)
Other Related Docs
9. Review on Interferon Beta: From Cells to Clinical Usage, Koomesh (2022)
10. Molecular Signaling Pathways, Pathophysiological Features in Various Organs, and Treatment Strategies in Sars-Cov2 Infection, Acta Histochemica (2022)
11. A Common Form of Dominant Human Ifnar1 Deficiency Impairs Ifn-Α and -Ω But Not Ifn-Β-Dependent Immunity, Journal of Experimental Medicine (2025)
12. The Role of Sars-Cov-2 Accessory Proteins in Immune Evasion, Biomedicine and Pharmacotherapy (2022)
13. Direct Antiviral Effects of Baicalin and Baicalein Against Sars-Cov-2: A Systematic Review, Current Nutrition and Food Science (2025)
14. Exploration of Blood−Derived Coding and Non-Coding Rna Diagnostic Immunological Panels for Covid-19 Through a Co-Expressed-Based Machine Learning Procedure, Frontiers in Immunology (2022)
15. Potential Therapeutic Applications of Extracellular Vesicles in the Immunopathogenesis of Covid-19, Pathology Research and Practice (2023)
16. Nanostructures for Prevention, Diagnosis, and Treatment of Viral Respiratory Infections: From Influenza Virus to Sars-Cov-2 Variants, Journal of Nanobiotechnology (2023)
17. Immunology, Immunopathogenesis and Immunotherapeutics of Covid-19; an Overview, International Immunopharmacology (2021)
18. Covid-19 Vaccine Boosters: The Good, the Bad, and the Ugly, Vaccines (2021)
19. Sars-Cov-2 Notable Mutations and Variants: A Review Article, Iranian Journal of Public Health (2022)
20. Novel Systemic Inflammation Markers to Predict Covid-19 Prognosis, Frontiers in Immunology (2021)
21. Therapeutic Strategies for Covid-19 Patients: An Update, Infectious Disorders - Drug Targets (2022)
22. Advances in Immunotherapy for Covid-19: A Comprehensive Review, International Immunopharmacology (2021)
23. Potential Antiviral Immune Response Against Covid-19: Lessons Learned From Sars-Cov, Advances in Experimental Medicine and Biology (2021)
24. Gastrointestinal Symptoms in Patients With Mild and Severe Covid-19: A Scoping Review and Meta-Analysis, Gastroenterology and Hepatology from Bed to Bench (2020)
25. Aging & Covid-19 Susceptibility, Disease Severity, and Clinical Outcomes: The Role of Entangled Risk Factors, Experimental Gerontology (2021)
26. An Outlook on Antigen-Specific Adoptive Immunotherapy for Viral Infections With a Focus on Covid-19, Cellular Immunology (2021)
27. Impact of Sars-Cov-2 Pandemic on Patients With Primary Immunodeficiency, Journal of Clinical Immunology (2021)
28. Interferon-Beta Offers Promising Avenues to Covid-19 Treatment: A Systematic Review and Meta-Analysis of Clinical Trial Studies, Naunyn-Schmiedeberg's Archives of Pharmacology (2021)
29. Covid-19: A Systematic Review and Update on Prevention, Diagnosis, and Treatment, MedComm (2022)
30. Anosmia: A Missing Link in the Neuroimmunology of Coronavirus Disease 2019 (Covid-19), Reviews in the Neurosciences (2020)
31. Covid-19 As a Trigger of Guillain-Barre Syndrome: A Review of the Molecular Mechanism, Immunity# Inflammation and Disease (2023)
32. Sars-Cov-2 Outbreak in Iran: The Dynamics of the Epidemic and Evidence on Two Independent Introductions, Transboundary and Emerging Diseases (2022)
33. Can Anti-Parasitic Drugs Help Control Covid-19?, Future Virology (2022)
34. Efficacy of Mrna, Adenoviral Vector, and Perfusion Protein Covid-19 Vaccines, Biomedicine and Pharmacotherapy (2022)
35. Covid-19 Pandemic and Periodontal Practice: The Immunological, Clinical, and Economic Points of View, BioMed Research International (2022)
36. The Controversial Effect of Smoking and Nicotine in Sars-Cov-2 Infection, Allergy# Asthma and Clinical Immunology (2023)
37. Molecular Study of Sars-Cov-2 Variants in Iranian Patients: A Multi-Center Study, Jundishapur Journal of Microbiology (2023)
38. Structure-Based Study of Immune Receptors As Eligible Binding Targets of Coronavirus Sars-Cov-2 Spike Protein, Journal of Molecular Graphics and Modelling (2021)
39. Clinical Manifestations of Covid-19, Advances in Experimental Medicine and Biology (2021)
40. Genomic Surveillance of Sars-Cov-2 Strains Circulating in Iran During Six Waves of the Pandemic, Influenza and other Respiratory Viruses (2023)
41. The Spike Protein Mutations and Its Effect on Sars-Cov-2 Pathogenesis, Journal of Cellular and Molecular Anesthesia (2021)
42. The Contributory Role of Lymphocyte Subsets, Pathophysiology of Lymphopenia and Its Implication As Prognostic and Therapeutic Opportunity in Covid-19, International Immunopharmacology (2021)
43. Molecular Variants of Sars-Cov-2: Antigenic Properties and Current Vaccine Efficacy, Medical Microbiology and Immunology (2022)
44. An Overview on the Seven Pathogenic Human Coronaviruses, Reviews in Medical Virology (2022)
45. Characteristics of Published/Registered Clinical Trials on Covid-19 Treatment: A Systematic Review, DARU# Journal of Pharmaceutical Sciences (2021)
46. Immunological Mechanisms of the Nucleocapsid Protein in Covid-19, Scientific Reports (2024)
47. The Role of Viral and Host Mirnas in the Control, Progression and Possible Treatment of Covid-19 Disease, Journal of Payavard Salamat (2022)
48. Precision Medicine in Infectious Disease, Precision Medicine in Clinical Practice (2022)
49. Whole-Genome Sequencing Reveals Host Factors Underlying Critical Covid-19, Nature (2022)
50. An Overview on the Treatments and Prevention Against Covid-19, Virology Journal (2023)